1. Home
  2. TUYA vs SVRA Comparison

TUYA vs SVRA Comparison

Compare TUYA & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

SELL

Current Price

$1.67

Market Cap

1.0B

Sector

Technology

ML Signal

SELL

Logo Savara Inc.

SVRA

Savara Inc.

SELL

Current Price

$4.74

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TUYA
SVRA
Founded
2014
2007
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
TUYA
SVRA
Price
$1.67
$4.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$3.17
★ $11.06
AVG Volume (30 Days)
655.3K
★ 2.3M
Earning Date
11-23-2026
11-11-2026
Dividend Yield
★ 6.78%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.58
N/A
Revenue Next Year
$11.55
$4,406.08
P/E Ratio
$27.45
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.60
$3.50
52 Week High
$2.61
$7.01

Technical Indicators

Market Signals
Indicator
TUYA
SVRA
Relative Strength Index (RSI) 42.80 38.36
Support Level $1.67 $4.73
Resistance Level $1.75 $5.53
Average True Range (ATR) 0.04 0.23
MACD 0.00 -0.01
Stochastic Oscillator 28.57 24.22

Price Performance

Historical Comparison
TUYA
SVRA

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness. All the Group's revenue are derived from within the PRC.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: